Zinner, R. G., Obasaju, C. K., Spigel, D. R., Weaver, R. W., Beck, J. T., Waterhouse, D. M., . . . Ross, H. J. (2015). PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer. J Thorac Oncol.
Chicago ZitierstilZinner, Ralph G., et al. "PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed By Maintenance Pemetrexed Versus Paclitaxel + Carboplatin + Bevacizumab Followed By Maintenance Bevacizumab in Patients Ith Advanced Nonsquamous Non–Small-Cell Lung Cancer." J Thorac Oncol 2015.
MLA ZitierstilZinner, Ralph G., et al. "PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed By Maintenance Pemetrexed Versus Paclitaxel + Carboplatin + Bevacizumab Followed By Maintenance Bevacizumab in Patients Ith Advanced Nonsquamous Non–Small-Cell Lung Cancer." J Thorac Oncol 2015.